A complete analysis of the Biotechnology & Genetics business, including trends, statistics and profiles of the 450 most successful Biotechnology companies, is available in the Biotech & Genetics Industry Almanac.

Represents subscriber only content.

• A Closer Look at the Drug Discovery and Development Process
  
  
• Annual Percent Change in U.S. Research & Development Spending by Research-Based Pharmaceutical Companies, 1980-2004
  
  
• Average Salaries in the U.S. Pharmaceutical and Biotechnology Industries: 2005
  
  
• Domestic R&D Spending as a Percentage of Domestic Sales, U.S. Research-Based Pharmaceutical Companies: 1970-2004

• Generics' Share of the U.S. Drug Market 1984-2004
  
  
• Global Agricultural Biotech At A Glance, 2004
  
  
• Global R&D Investments by Research-Based Pharmaceutical Companies: 1970-2004
  
  
• Largest Global Pharmaceutical Companies
  
  
• New U.S. Biotech Drug and Vaccine and Indication Approvals, 1982-2004
  
  
• Profile of U.S. Public Biotech Companies, 2000-2004
  
  
• Total U.S. Biotechnology Patents Granted Per Year, 1989-2004
  
  
• U.S. Biotech Industry Financings, 1996-2004
  
  
• U.S. Drug and Biopharmaceutical Development Times 1985-2004
  
  
• U.S. Drug Discovery and Approval Process
  
  
• U.S. FDA Approval Times for New Drugs, 1993-2004
  
  
• U.S. FDA Approval Times for New Molecular Entities (NMEs*), 1993-2004
  
  
• U.S. National Science Foundation Biological Sciences Research Funding, Fiscal Year 2003-2005
  
  
• U.S. Pharmaceutical R&D Spending Versus Number of New Drug Approvals (NMEs*), 1993-2004

For a complete analysis and further discussion of statistics, trends and more:
Purchase Plunkett's Biotech & Genetics Industry Almanac or the eBook (PDF) Version by download.

 

Back to the Health Care & Biotechnology Industry Channel